Ohno Yasuo | Div. Of Pharmacology Biological Safty Research Center National Institute Of Hygienic Sciences
スポンサーリンク
概要
- 同名の論文著者
- Div. Of Pharmacology Biological Safty Research Center National Institute Of Hygienic Sciencesの論文著者
関連著者
-
Ohe Yuichiro
国立医薬品食品衛生研究所
-
Ohe Yuichiro
Department Of Medical Oncology National Cancer Center Hospital
-
OHNO Yasuo
Division of Pharmacology, National Institute of Health Science
-
Ohe Yuichiro
Thoracic Oncology Division National Cancer Center Hospital National Cancer Center
-
Ohe Yuichiro
Department Of Internal Medicine National Cancer Center Hospital
-
Tamura T
Division Of Internal Medicine National Cancer Center Hospital
-
Tamura Tomohide
国立がんセンター中央病院 腫瘍内科
-
Tamura T
National Cancer Center Hospital Tokyo
-
Tamura Tomohide
Medical Oncology Division National Cancer Center Hospital
-
Ozawa Shogo
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Saijo N
Division Of Internal Medicine National Cancer Center Hospital East
-
Saijo Nagahiro
国立医薬品食品衛生研究所
-
Saijo N
Medical Oncology National Cancer Center Hospital
-
Yamamoto N
Thoracic Oncology Division National Cancer Center Hospital National Cancer Center
-
Kanzaki Hideaki
国立循環器病センター 心臓血管内科
-
Yamamoto Noboru
国立医薬品食品衛生研究所
-
OZAWA Shogo
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
SAWADA Jun-ichi
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
SAITO Yoshiro
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
Kawamoto Manabu
Institute Of Rheumatology Tokyo Women's Medical University
-
Kitajima Satoshi
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Tamura Tomohide
国立がんセンター中央病院 相談支援センター
-
Tamura Tomohide
Medical Oncology National Cancer Center Hospital
-
Sawada Junichi
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Kitakaze Masafumi
国立循環器病センター 心臓血管
-
Kitakaze Masafumi
Nagoya University Graduate School Of Medicine
-
Yoshida S
Chiba University
-
Saito Y
Department Of Cardiovascular Medicine Osaka University Graduate School Of Medicine
-
Kaniwa N
Department Of Genome Biology Kinki University School Of Medicine
-
Yoshida Teruhiko
Genetics Division National Cancer Center Research Institute National Cancer Center
-
Yoshida Teruhiko
国立循環器病センター 疫学部
-
Kurose K
Department Of Vascular Physiology Research Institute National Cardiovascular Center
-
MAEKAWA Keiko
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
Kawamoto Manabu
Division Of Genomic Medicine Department Of Advanced Biomedical Engineering And Science Tokyo Women&a
-
Miyashita K
Department Of Cardiovascular Surgery National Cardiovascular Center
-
Koseki Masahiro
大阪大学 医学系研究科循環器内科学
-
Kamatani Naoyuki
国立医薬品食品衛生研究所 薬物応答予測プロジェクト
-
Maekawa Keiko
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Saito Yoshihiko
Department Of Clinical Cell Biology Chiba University Graduate School Of Medicine
-
Sai Kimie
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
KANIWA Nahoko
Project team for Pharmacogenetics, National Institute of Health Sciences
-
YAMAMOTO Noboru
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
YAMAMOTO Noboru
Division of Internal Medicine, National Cancer Center Hospital
-
KUNITOH Hideo
Division of Internal Medicine, National Cancer Center Hospital
-
OHE Yuichiro
Division of Internal Medicine, National Cancer Center Hospital
-
TAMURA Tomohide
Division of Internal Medicine, National Cancer Center Hospital
-
Kitakaze Masafumi
Division Of Cardiology National Cardiovascular Center
-
YAMADA Yasuhide
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
Kawamoto Manabu
国立医薬品食品衛生研究所
-
Komamura K
Department Of Cardiovascular Dynamics Research Institute National Cardiovascular Center
-
Hamaguchi Tetsuya
国立がんセンター中央病院 消化管内科グループ
-
Hamaguchi T
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Hamaguchi T
Gastrointestinal Oncology Division National Cancer Center Hospital National Cancer Center
-
Hamaguchi Tetsuya
Data Storage Systems Division Hitachi Ltd.
-
Hamano Tetsutaro
国立がんセンター中央病院 腫瘍内科
-
Yamada Y
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Yamada Yasuhide
国立がんセンター中央病院 消化管内科グループ
-
Yamada Yasuhide
国立がんセンター中央病院
-
Yamada Yasuhide
Medical Oncology Division National Cancer Center Hospital
-
SAI Kimie
Project team for Pharmacogenetics, National Institute of Health Sciences
-
Ohtsu A
Gastrointestinal/oncology Division National Cancer Center Hospital
-
Ohtsu Atsushi
国立医薬品食品衛生研究所 機能生化学部
-
KUROSE Kouichi
Project team for Pharmacogenetics, National Institute of Health Sciences
-
KUNITOH Hideo
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
OHE Yuichiro
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
NOKIHARA Hiroshi
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
SOYAMA Akiko
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
Saeki Mayumi
国立医薬品食品衛生研究所 機能生化学部
-
Saeki Mayumi
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Tomoike Hitonobu
国立循環器病センター 疫学部
-
Kurose Kouichi
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Hashimoto Katsuji
Division Of Cardiology National Cardiovascular Center
-
SAITO Yasushi
Chiba University
-
YOSHIDA Teruhiko
Genetics Division, National Cancer Center Research Institute
-
Nonogi Hiroshi
国立循環器病センター研究所 疫学部
-
Nakagami Hironori
Division Of Gene Therapy Science Osaka University Graduate School Of Medicine
-
Nonogi H
Division Of Cardiology Department Of Internal Medicine National Cardiovascular Center
-
ITODA Masaya
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
Kosugi Takayoshi
Department Of Pharmacy National Cardiovascular Center
-
MINAMI Hironobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Kosuge Kotoko
日本大学 医学部内科学系腎臓高血圧内分泌内科
-
Kosuge Kotoko
Division Of Nephrology Hypertension And Endocrinology Department Of Medicine Nihon University School
-
Itoda Masaya
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Itoda Masaya
国立医薬品食品衛生研究所
-
Kodama K
Cardiovascular Division Osaka Police Hospital
-
OHTSU Atsushi
Division of GI Oncology/Digestive Endoscopy, National Cancer Center Hospital East
-
Minami Hironobu
Division Of Oncology/hematology National Cancer Center Hospital East
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Minami Hironobu
名古屋第一赤十字病院
-
Minami Hironobu
National Cancer Center Hospital East
-
Ohtsu Atsushi
Division Of Gastrointestinal Oncology/digestive Endoscopy National Cancer Center Hospital East
-
KATORI Noriko
Project team for Pharmacogenetics, National Institute of Health Sciences
-
TAMURA Tomohide
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
SAIJO Nagahiro
Deputy Director, National Cancer Center Hospital East
-
FUKUSHIMA UESAKA
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
YOSHIDA Teruhiko
Genomics Division, National Cancer Center Research Institute, National Cancer Center
-
SAEKI Mayumi
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
Katori Noriko
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
KOMAMURA Kazuo
Department of Cardiovascular Dynamics, Research Institute, National Cardiovascular Center
-
Umemura T
Division Of Pathology National Institute Of Health Sciences
-
Honda Hiroyuki
Department of Biotechnology, School of Engineering, Nagoya University
-
高橋 通正
(独)産業技術総合研究所 環境管理技術研究部門
-
Naritomi Hiroaki
Division Of Cardiology National Cardiovascular Center
-
SUZUKI Yoshihiko
Suzuki clinic
-
HAMAGUCHI Tetsuya
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
SHIMADA Yasuhiro
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
KAMATANI Naoyuki
Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women
-
Kosugi Takayoshi
東邦大学医学部附属大森病院 薬剤
-
Kamakura Shiro
Department Of Cardiovascular Surgery National Cardiovascular Center
-
Shirao K
Department Of Cardiovascular Surgery National Cardiovascular Center
-
Yasuhara K
Division Of Pathology National Institute Of Health Sciences
-
Yasuhara Kazuo
Division Of Pathology National Institute Of Health Sciences
-
Kasai Satoshi
国立循環器病センター 心臓血管内科
-
HASEGAWA Ryuichi
Division of Medical Safety Science, National Institute of Health Sciences
-
Shirao Kuniaki
Gastrointestinal Oncology Division National Cancer Center Hospital
-
SEKINE Ikuo
Thoracic Oncology Division, National Cancer Center Hospital, National Cancer Center
-
SHIRAO Kuniaki
Division of Internal Medicine, National Cancer Center Hospital
-
HAMAGUCHI Tetsuya
Division of Internal Medicine, National Cancer Center Hospital
-
YAMADA Yasuhide
Division of Internal Medicine, National Cancer Center Hospital
-
MATSUMURA Yasuhiro
Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Ho
-
SAIJO Nagahiro
National Cancer Center Hospital East
-
YAMAMOTO Noboru
Department of Medical Oncology, National Cancer Center Hospital, National Cancer Center Research Ins
-
SAIJO Nagahiro
Division of Internal Medicine, National Cancer Center Hospital, National Cancer Center
-
MURAYAMA Norie
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
Shimo T
National Inst. Health Sci. Tokyo
-
Kitakaze Masafumi
Department Of Cardiology National Cardiovascular Center
-
Tomoike Hitonobu
国立循環器病センター研究所 疫学部
-
Murayama N
Division Of Xenobiotic Metabolism And Disposition
-
Murayama Norie
Project Team For Pharmacogenetics National Institute Of Health Science
-
KATOH Takahiko
Department of Public Health, Faculty of Life Sciences, Kumamoto University
-
Suzuki Sachiko
Division Of Toxicology Biological Safety Research Center National Institute Of Health Sciences
-
Kawasaki Nana
Division Of Biological Chemistry And Biologicals National Institute Of Health Sciences
-
YAMAMOTO Nobuyuki
Department of Chemistry and Materials Engineering, Faculty of Chemistry, Materials and Bioengineerin
-
Kitamura K
Department Of Geriatric Medicine Ehime University Graduate School Of Medicine
-
Kikuchi Kenjiro
Second Department Of Internal Medicine Sapporo Medical College
-
EGUCHI NAKAJIMA
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
KATO Ken
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
KIM Su-Ryang
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
KAWAMOTO Manabu
Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women
-
Kamide Kei
国立循環器病センター 高血圧腎臓内科
-
Noda Takashi
国立循環器病センター 心臓血管内科
-
Kamakura Shiro
国立循環器病センター
-
Suyama Kazuhiro
国立循環器病センター 心臓血管内科
-
UMEMURA Takashi
Division of Pathology, National Institute of Health Sciences
-
Nonogi Hiroshi
Cardiology And Emergency Medicine National Cardiovascular Center
-
KIMURA Kenjiro
St. Marianna University School of Medicine
-
Saito Y
Division Of Cardiovascular Medicine Kumamoto University Graduate School Of Medical Sciences
-
松本 宜明
日本大学薬学部臨床薬物動態学ユニット
-
Saito Yoshiro
国立医薬品食品衛生研究所
-
Eguchi Nakajima
Gastrointestinal Oncology Division National Cancer Center Hospital
-
Kim Su-ryang
国立医薬品食品衛生研究所
-
Kim Su-ryang
Project Team For Pharmacogenetics National Institute Of Health Sciences
-
Yamashita Shizuya
大阪大学 医学系研究科循環器内科学
-
SHIMIZU Makiko
Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University
-
Kosuge Masami
Yokohama City University School Of Medicine
-
Suzuki Shugo
名古屋市立大学 医学研究科実験病態病理学分野
-
NAKAMURA Takahiro
Project team for Pharmacogenetics, National Institute of Health Sciences
-
SHIRAO Kuniaki
Gastrointestinal Oncology Division, National Cancer Center Hospital
-
SAIJO Nagahiro
Medical Oncology Division, National Cancer Center Hospital
-
Shirao Kuniaki
国立医薬品食品衛生研究所
-
Sawada Junichi
Division Of Biochemistry And Immunochemistry National Institute Of Health Sciences (nihs)
-
Sai Kimie
Divislon Of Toxicology National Institute Of Health Sciences
-
Sai Kimie
Division Of Biosignaling National Institute Of Health Sciences
-
Ohtsu Atsushi
国立がんセンター東病院 消化管内科
-
Ohtsu A
National Cancer Center Hospital East Chiba Jpn
-
Nakajima T
National Center For Child Health And Dev. Tokyo Jpn
-
Nakajima Toshiharu
国立医薬品食品衛生研究所
-
Kobayashi Takashi
Icd Committee Of The Japanese Heart Rhythm Society
-
TATEWAKI Naoko
Project team for Pharmacogenetics, National Institute of Health Sciences
-
SUGIYAMA Emiko
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
NISHIMAKI MOGAMI
Division of Functional Biochemistry and Genomics, National Institute of Health Sciences
-
UKAJI Maho
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
DOI Toshihiko
Division of GI Oncology/Digestive Endoscopy, National Cancer Center Hospital East
-
JINNO Hideto
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
UENO Kazuyuki
Department of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences
-
KOYANO Satoru
Project team for Pharmacogenetics, National Institute of Health Sciences
-
NAKAJIMA Osamu
Division of Biochemistry and Immunochemistry National Institute of Health Sciences
-
ISHIDA Seiichi
Project Team for Pharmacogenetics, National Institute of Health Sciences
-
NAKAJIMA Yukiko
Project Team for Pharmacogenetics, National Institute of Health Science
-
KANIWA Naoko
Division of Drugs, National Institute of Health Science
-
Yasuhara Kazuo
National Institute of Health Sciences
-
Mitsumori Kunitoshi
National Institute of Health Sciences
-
Muto Manabu
国立がんセンター東病院 消化管内科
-
Muto Manabu
Division Of Gastrointestinal Oncology And Digestive Endoscopy National Cancer Center Hospital East
-
Matsumura Y
Investigative Treatment Division Research Center For Innovative Oncology National Cancer Center Hosp
-
Jinno H
Nationl Inst. Health Sci. Tokyo Jpn
-
Jinno Hideto
Project Team For Pharmacogenetics Division Of Biochemistry And Immunochemistry Division Of Environme
-
Ueno K
Department Of Pharmaceutical Sciences Niigata University Of Pharmacy And Applied Life Sciences
-
Ueno Kazuyuki
国立医薬品食品衛生研究所 薬物応答予測プロジェクト
-
Ueno Kazuyuki
新潟薬科大学 薬剤学
-
Takegawa K
Division Of Pathology National Institute Of Health Sciences:safety Evaluation Drug Development Labor
-
Takegawa Kiyoshi
三菱ウェルファーマ
-
Takada Koichi
Safety Evaluation Laboratory Yoshitomi Pharmaceutical Industries Co. Ltd.
-
Takegawa K
Toxicology Laboratories Pharmaceutical Research Division Mitsubishi Pharma Corporation
-
Takegawa Kiyoshi
Department Of Pathology National Institute Of Health Sciences
-
Nishimaki Mogami
Division Of Biosignaling National Institute Of Health Sciences
-
Nishimaki Mogami
Division Of Functional Biochemistry And Genomics National Institute Of Health Sciences
-
Nakajima Yukiko
国立医薬品食品衛生研究所
-
Nakajima Y
Project Team For Pharmacogenetics National Institute Of Health Sciences
著作論文
- Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
- 日本人におけるGSTT1及びGSTM1の遺伝子多型の同定及びハプロタイプ構造の解析
- Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
- Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
- Expression of CYP2A6 in Tumor Cells Augments Cellular Sensitivity to Tegafur
- Three novel single nucleotide polymorphisms in UGT1A10
- Sequence-based Analysis of the CYP2D6^*36-CYP2D6^*10 Tandem-type Arrangement, a Major CYP2D6^*10 Haplotype in the Japanese Population
- 21C-03-4 Effects of 2-Mercaptobenzimidazole (MBI) and its methyl derivatives MMBI on rat hepatic drug metabolizing enzymes.
- 21C-03-3 Effects of Diphenyl on Hepatic Peroxysomal Enzyme and Drug-Metabolizing Enzyme Activities in BDF1 Mice.
- Sulfating-Activity and Stability of cDNA-Expressed Allozymes of Human Phenol Sulfotransferase, ST1A31 (^Arg) and ST1A32 (^His), Both of Which Exist in Japanese as Well as Caucasians^1
- 2C-17 Effects of Substituted Phenylurea Pesticides and Their Metabolites in Freshly Isolated and Cultured Rat Hepatocytes.
- "B-11 Effects of triazine herbicides on isolated and primary cultured hepatocytes of rat.
- EFFECT OF CARBAMATES ON RAT HEPATOCYTES IN THE PRIMARY CULTURE
- EFFECT OF CARBAMATES ON RAT FRESHLY ISOLATED HEPATOCYTES
- THE EFFECT OF DIQUAT ON THE GAP JUNCTIONAL INTERCELLULAR COMMUNICATION BETWEEN RAT HEPATOCYTES IN PRIMARY CULTURE
- EFFECT OF ORGANOPHOSPHORUS COMPOUNDS AND THEIR METABOLITES ON RAT FRESHLY ISOLATED HEPATOCYTES
- EFFECTS OF ORGANIC PHOSPHOROUS COMPOUNDS AND THEIR METABOLITES ON RAT HEPATOCYTES IN THE PRIMARY CULTURE
- Gene Expression Property of High-Density Three-Dimensional Tissue of HepG2 Cells Formed in Radial-Flow Bioreactor(BIOINFORMATICS)
- Three-Dimensional High-Density Culture of HepG2 Cells in a 5-ml Radial-Flow Bioreactor for Construction of Artificial Liver(Biochemical Engineering)
- 日本人で新たに見いだされた低活性型CYP2D6ハプロタイプ
- CYP3A4 Gene Polymorphisms Influence Testosterone 6β-hydroxylation
- P-103 Collaborative Work to Evaluate Toxicity on Male Reproductive Organs by A 2-Week Repeated-Dose Toxicity Study in Rats : 29)Summary.(Proceedings of the 27th Annual Meeting)
- COLLABORATIVE WORK TO EVALUATE TOXICITY ON MALE REPRODUCTIVE ORGANS BY REPEATED DOSE STUDIES IN RATS : OVERVIEW OF THE STUDIES
- EFFECT OF PHOSPHORIC ACID TRI-ESTERS FLAME RETARDANTS ON THE PRENATAL AND POSTNATAL DEVELOPMENTS OF THE RATS
- Ethnic Differences in Genetic Polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1
- Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity
- Problems with Registration-Directed Clinical Trials for Lung Cancer in Japan
- Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
- Tumor response to chemotherapy : The validity and reproducibility of RECIST guidelines in NSCLC patients
- Prospective Evaluation of the Feasibility of Cisplatin-based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions
- 21C-01-3 Genetic polymorphisms of carcinogen-activating human phenol sulfotransferase and arylamine n-acetyltransferase, and urothelial cancer susceptibiltiy.
- STUDY ON THE TOXICITY OF 2,2'-METHYLENE-bis(4-ETHYL-6-tert-BUTYLPHENOL) IN RAT (NO.1)
- Improvement in Reliability of Probabilistic Test of Significant Differences in GeneChip Experiments
- TOXICITY STUDIES OF A SYNTHETIC ANTIOXIDANT, 2,2'-METHYLENEBIS (4-ETHYL-6-TERT-BUTYLPHENOL) IN RATS 2. UNCOUPLING EFFECT ON OXIDATIVE PHOSPHORYLATION OF LIVER MITOCHONDRIA
- Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A)
- STUDIES ON NITROSAMINE FORMATION BY THE INTERACTION BETWEEN DRUGS AND NITRITE. I. : Measurement of the amount of nitrosamine formed in rat and guinea pig stomachs.
- EFFECTS ON FETAL GROWTH OF REPEATED BLOOD COLLECTION FOR TOXICOKINETICS FROM PREGNANT RATS
- Genetic Polymorphisms of Copper- and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients
- O-35 Benefits of surgical materials in drug development(Proceedings of the 27th Annual Meeting)
- "B-3 Toxicokinetic Study of 2-Mercaptobenzimidazole (MBI) and its Methylated Derivative (MMBI) in Rats after Single Oral-Dose Administration.
- Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
- LOSS OF VIABILITY AFTER DISULFIRAM TREATMENT WITHOUT PRECEDING DEPLETION OF INTRACELLULAR GSH
- ORIGIN AND CHARACTERISTICS OF FRESHLY ISOLATED RENAL CELLS OBTAINED BY PERFUSION OF COLLAGENASE IN VITRO
- MORPHINE METABOLISM IN ISOLATED HEPATOCYTES AND ITS IMPLICATIONS FOR HEPATOTOXICITY
- COMPARISONS OF THE TOXICOKINETIC PARAMETERS IN RATS DETERMINED FOR LOW AND HIGH DOSE OF γ-CHLORDANE
- FETAL TOXICITY OF ZINC ETHYLPHENYLDITHIOCARBAMATE(ZEPC)(3). MECHANISM OF FORMATION OF METHEMOGLOBIN CAUSED BY ZEPC
- COMPARATIVE STUDY ON METABOLISM OF N-NITROSODIMETHYLAMINE AND N-NITROSOMETHYLBENZYLAMINE IN RAT LIVER
- RENAL MICROSOMAL N-NITROSODIMETHYLAMINE DEMETHYLASE DETERMINED BY A SENSITIVE RADIOMETRIC METHOD
- INFLUENCE OF DOSE ON THE TOXICOKINETICS OF γ-CHLORDANE
- STUDIES ON NITROSAMINE FORMATION BY THE INTERACTION BETWEEN DRUGS AND NITRITE. II. : Hepatotoxicity by the simultaneous administration of several drugs and nitrite.
- COMPARATIVE TOXICOKINETIC STUDY OF RUBBER ANTIOXIDANTS, 2-MERCAPTOBENZIMIDAZOLE AND 2-MERCAPTOMETHYLBENZIMIDAZOLE, BY SINGLE ORAL ADMINISTRATION IN RATS
- 22D-11-3 Increased Liver and Kidney Toxicities in Rats Caused by Co-administration of 2-Mercaptobenzimidazole (MBI) and Lipopolysaccharide (LPS) and Their Toxicokinetics (TK).
- Comparison of Thyroid Toxicity and Toxicokinetics of 2-Mercapto-4-methylbenzimidazole (4MeMBI) and its 5-Methyl Isomer (5MeMBI), Rubber antioxidant, in Rats by Single and Repeated Oral-Dose Administrations
- Endogenous Nitric Oxide Formation Stimulated by LPS in Hypothyroid Rats Induced by 2-Mercaptobenzimidazole (MBI)
- 2C-13 Toxicokinetic Study of 2-Mercapto-benzimidazole(MBI) and its Methylated Derivative (MMBI) in Rats Treated by Repeated Oral Administration - Metabolism and urinary Excretion
- 2C-12 Toxicokinetic Study of 2-Mercapto-benzimidazole(MBI) and its Methylated Derivative (MMBI) in Rats Treated by Repeated Oral Administration.
- 219 EFFECTS OF 2-MONOCHLORODIBENZOFURAN AND 3-MONOCHLORODIBENZOFURAN ON THE P450-MEDIATED DRUG METABOLIZING ENZYME ACTIVITIES OF PRIMARY CULTURED RAT HEPATOCYTES : COMPARISION WITH THE EFFECTS OF DIOXINS AND METHLCHOLANTHRENE
- 215 MUTAGENIC ACTIVATION OF 2- AND 3-CHLORODIBENZOFURANS BY LIVER MICROSOMES AND THE CORRELATION WITH CYTOCHROME P-450 ISOZYMES
- A04 EFFECTS OF METYRAPONE ON THE CYTOCHROME P450 MEDIATED DRUG METABOLIZING ACTIVITIES IN THE PRIMARY CULTURES OF RAT HEPATOCYTES
- STUDIES ON THE ESTABLISHMENT OF APPROPRIATE SPERMATOGENIC ENDPOINTS FOR MALE FERTILITY DISTURBANCE IN RODENT INDUCED BY DRUGS AND CHEMICALS I. NITROBENZENE
- A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38
- EFFECTS OF VARIOUS INDUCERS ON THE ACTIVITIES OF CYTOCHROME P-450-MIXED FUNCTION OXIDASES AND AFLATOXIN B_1 ACTIVATION IN MICROSOMES OF HAMSTER LIVERS
- EFFECTS OF TRIS (2, 3-DIBROMOPROPYL) PHOSPHATE ON THE PRENATAL AND POSTNATAL DEVELOPMENTS OF THE RATS (The 6th Meeting for the Study of Toxic Effect)
- STUDIES ON THE TERATOGENICITY OF FURYLFURAMIDE IN FETUSES AND OFFSPRING OF RATS IN RELATION TO FETAL DISTRIBUTION
- Toxicity Evaluation by using primary cultured rat hepatocytes
- W4-3 Toxicity Evaluation by using primary cultured rat hepatocytes
- EFFECT OF INTRAMUSCULAR INJECTION OF DRUGS ON SERUM CPK ACTIVITY IN RABBITS
- TERATOLOGICAL STUDIES OF ZINC ETHYLPHENYLDITHIOCARBAMATE (ZEPC), A VULCANIZATION ACCELERATOR FOR RUBBERS, IN RATS
- A new device for the determination of microsomal cytochrome P-450 in renal tissue preparations from various species contaminated with mitochondria and hemoglobin.